Programmed Death-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Expression in Aggressive Pediatric Lymphomas

被引：0
|
作者：
Coffey, Amy M.
Curry, Jonathan L.
Marcogliese, Andrea N.
Tetzlaff, Michael T.
Kamdar, Kala
Elghetany, Mohamed T.
Curry, Choladda V.
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Texas Childrens Hosp, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1379
引用
收藏
页码：344A / 344A
页数：1
相关论文
共 50 条
  • [41] Programmed death-ligand 1 (PD-L1) expression in small bowel adenocarcinomas (SBA)
    Pedersen, Katrina
    Smyrk, Thomas C.
    Harrington, Susan
    McWilliams, Robert R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] Programmed Death-Ligand 1 (PD-L1) Expression in Upper Tract Urothelial Carcinoma
    Skala, Stephanie
    Liu, Tzu-Ying
    MUdager, Aaron
    Weizei, Alon Z.
    Montgomery, Jeffrey S.
    Palapattu, Ganesh S.
    Siddiqui, Javed
    Cao, Xuhong
    Fields, Kristina
    Abugharib, Ahmed E.
    Soliman, Moaaz
    Hafez, Khaled S.
    Miller, David
    Lee, Cheryl T.
    Alva, Ajjai
    Chinnaiyan, Arul M.
    Morgan, Todd M.
    Sprott, Daniel E.
    Jiang, Hui
    Mehra, Rohit
    [J]. LABORATORY INVESTIGATION, 2017, 97 : 260A - 260A
  • [43] Programmed death-ligand 1 (PD-L1) and programmed cell death protein 1 (PD-1) expression in bladder cancer (BC): Differences in recurrent, progressive, and metastatic disease.
    Hegele, Axel
    Wahl, Franziska
    Rexin, Peter
    Nimphius, W.
    Hofmann, Rainer
    Haenze, Joerg
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumor
    Suteau, Valentine
    Collin, Alexandre
    Menei, Philippe
    Rodien, Patrice
    Rousselet, Marie-Christine
    Briet, Claire
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (10) : 2053 - 2061
  • [45] Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non -Small Cell Lung Carcinoma
    Driver, Brandon
    Miller, Ross A.
    Deavers, Michael
    Tacha, David
    Bernicker, Eric
    Cagle, Philip T.
    [J]. MODERN PATHOLOGY, 2017, 30 : 475A - 475A
  • [46] Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer
    Maureen L. Drakes
    Swati Mehrotra
    Monica Aldulescu
    Ronald K. Potkul
    Yueying Liu
    Anne Grisoli
    Cara Joyce
    Timothy E. O’Brien
    M. Sharon Stack
    Patrick J. Stiff
    [J]. Journal of Ovarian Research, 11
  • [47] Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand-1 (PD-L1) in ovarian cancer
    Drakes, Maureen L.
    Mehrotra, Swati
    Aldulescu, Monica
    Potkul, Ronald K.
    Liu, Yueying
    Grisoli, Anne
    Joyce, Cara
    O'Brien, Timothy E.
    Stack, M. Sharon
    Stiff, Patrick J.
    [J]. JOURNAL OF OVARIAN RESEARCH, 2018, 11
  • [48] Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis
    Matsuda, Kotaro
    Miyoshi, Hiroaki
    Hiraoka, Koji
    Hamada, Tetsuya
    Yoshida, Shiro
    Ishibashi, Yukinao
    Haraguchi, Toshiaki
    Shiba, Naoto
    Ohshima, Koichi
    [J]. CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 18 (04) : 487 - 494
  • [49] Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis
    Kotaro Matsuda
    Hiroaki Miyoshi
    Koji Hiraoka
    Tetsuya Hamada
    Shiro Yoshida
    Yukinao Ishibashi
    Toshiaki Haraguchi
    Naoto Shiba
    Koichi Ohshima
    [J]. Clinical and Experimental Medicine, 2018, 18 : 487 - 494
  • [50] Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Expression Patterns in Ewing and Ewing-Like Sarcoma
    Tamura, A.
    Yoshida, M.
    Yamamoto, N.
    Nakamura, S.
    Fujiwara, T.
    Tahara, T.
    Saito, A.
    Kozaki, A.
    Kishimoto, K.
    Ishida, T.
    Hasegawa, D.
    Kosaka, Y.
    [J]. PEDIATRIC BLOOD & CANCER, 2018, 65 : S336 - S336
12345